HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 294/4/C994    most recent 00563.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Kuns-Hashimoto, R. Articles by Rotwein, P. Search for Related Content PubMed PubMed Citation Articles by Kuns-Hashimoto, R. Articles by Rotwein, P.

RECEPTORS AND SIGNAL TRANSDUCTION

Selective binding of RGMc/hemojuvelin, a key protein in systemic iron metabolism, to BMP-2 and neogenin

Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, Oregon

Submitted 27 November 2007 ; accepted in final form 14 February 2008

Juvenile hemochromatosis is a severe and rapidly progressing hereditary disorder of iron overload, and it is caused primarily by defects in the gene encoding repulsive guidance molecule c/hemojuvelin (RGMc/HJV), a recently identified protein that undergoes a complicated biosynthetic pathway in muscle and liver, leading to cell membrane-linked single-chain and heterodimeric species, and two secreted single-chain isoforms. RGMc modulates expression of the hepatic iron regulatory factor, hepcidin, potentially through effects on signaling by the bone morphogenetic protein (BMP) family of soluble growth factors. To date, little is known about specific pathogenic defects in disease-causing RGMc/HJV proteins. Here we identify functional abnormalities in three juvenile hemochromatosis-linked mutants. Using a combination of approaches, we first show that BMP-2 could interact in biochemical assays with single-chain RGMc species, and also could bind to cell-associated RGMc. Two mouse RGMc amino acid substitution mutants, D165E and G313V (corresponding to human D172E and G320V), also could bind BMP-2, but less effectively than wild-type RGMc, while G92V (human G99V) could not. In contrast, the membrane-spanning protein, neogenin, a receptor for the related molecule, RGMa, preferentially bound membrane-associated heterodimeric RGMc and was able to interact on cells only with wild-type RGMc and G92V. Our results show that different isoforms of RGMc/HJV may play unique physiological roles through defined interactions with distinct signaling proteins and demonstrate that, in some disease-linked RGMc mutants, these interactions are defective.

repulsive guidance molecule; juvenile hemochromatosis; bone morphogenetic protein

This article has been cited by other articles:

				A.-S. Zhang, F. Yang, J. Wang, H. Tsukamoto, and C. A. Enns Hemojuvelin-Neogenin Interaction Is Required for Bone Morphogenic Protein-4-induced Hepcidin Expression J. Biol. Chem., August 21, 2009; 284(34): 22580 - 22589. [Abstract] [Full Text] [PDF]

				K. Hata, K. Kaibuchi, S. Inagaki, and T. Yamashita Unc5B associates with LARG to mediate the action of repulsive guidance molecule J. Cell Biol., March 9, 2009; 184(5): 737 - 750. [Abstract] [Full Text] [PDF]

				J. E. Maxson, C. A. Enns, and A.-S. Zhang Processing of hemojuvelin requires retrograde trafficking to the Golgi in HepG2 cells Blood, February 19, 2009; 113(8): 1786 - 1793. [Abstract] [Full Text] [PDF]

				A. Pagani, L. Silvestri, A. Nai, and C. Camaschella Hemojuvelin N-terminal mutants reach the plasma membrane but do not activate the hepcidin response Haematologica, October 1, 2008; 93(10): 1466 - 1472. [Abstract] [Full Text] [PDF]